Table 1.
Flavonoid/metabolite |
logIC50±SEM (M) |
Rmax±SEM (aggregation-% of control) |
Hill slope±SEM |
|||
---|---|---|---|---|---|---|
Aggregation | 5-HT secretion | Aggregation | 5-HT secretion | Aggregation | 5-HT secretion | |
Quercetin | −5.17 ± 0.04 | −5.11 ± 0.02 | 100 ± 0 | 96 ± 0 | −2.79 ± 0.69 | −2.04 ± 0.27 |
Tamarixetin | −4.75 ± 0.05 | −4.66 ± 0.18 | 96 ± 4 | 83 ± 3 | −2.99 ± 0.80 | −1.69 ± 0.60 |
Quercetin-3′-sulphate | −4.72 ± 0.01 | −4.73 ± 0.03 | 100 ± 0 | 100 ± 0 | −10.71 ± 2.49 | −2.48 ± 0.41 |
Apigenin | −5.31 ± 0.04 | −5.36 ± 0.04 | 100 ± 0 | 87 ± 2 | −2.23 ± 0.43 | −2.19 ± 0.32 |
Catechin | −3.44 ± 0.05 | −3.45 ± 0.04 | 100 ± 0 | 100 ± 0 | −2.91 ± 0.82 | −1.51 ± 0.19 |
Potencies were calculated as the concentration of flavonoids (quercetin, apigenin and catechin) or metabolites (tamarixetin and quercetin-3′-sulphate) that inhibited aggregation or 5-HT secretion by 50% (IC50). LogIC50 values were calculated using non-linear regression and a variable Hill slope with inhibition constants (maximum and minimum % aggregation) individually determined for each compound. The SEM was derived from logIC50 of three individual data sets.